Plasma concentrations of glucagon-like peptide-2 in adult patients with treated and untreated coeliac disease
Data(s) |
01/02/2006
|
---|---|
Resumo |
Coeliac disease is a common chronic inflammatory enteropathy characterized by villous atrophy and crypt hyperplasia in the small intestine. The mechanism of the intestinal damage in coeliac disease remains unclear. Glucagon-like peptide (GLP)-2 is an enterotrophic peptide that causes crypt hyperplasia and intestinal cell proliferation. We postulate that GLP-2 may be involved in the mucosal changes found in coeliac disease. |
Identificador | |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Caddy , G R , Ardill , J E S , Fillmore , D , Caldwell , C M , McKibben , B M , Gardiner , K R & Watson , P R G 2006 , ' Plasma concentrations of glucagon-like peptide-2 in adult patients with treated and untreated coeliac disease ' European journal of gastroenterology & hepatology , vol 18 , no. 2 , pp. 195-202 . |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700/2715 #Gastroenterology |
Tipo |
article |